BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36513904)

  • 21. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
    Njauw CN; Kim I; Piris A; Gabree M; Taylor M; Lane AM; DeAngelis MM; Gragoudas E; Duncan LM; Tsao H
    PLoS One; 2012; 7(4):e35295. PubMed ID: 22545102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
    Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
    Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.
    Sengupta S; Weyand AC; Upadhyaya SA; Wu YM; Robinson DR; Mody RJ
    J Pediatr Hematol Oncol; 2019 May; 41(4):e263-e265. PubMed ID: 29554022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer.
    Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
    Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H
    JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
    Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome.
    Lalloo F; Kulkarni A; Chau C; Nielsen M; Sheaff M; Steele J; van Doorn R; Wadt K; Hamill M; Torr B; Tischkowitz M; ; Hanson H
    Eur J Hum Genet; 2023 Nov; 31(11):1261-1269. PubMed ID: 37607989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uveal Melanoma in BAP1 Tumor Predisposition Syndrome: Estimation of Risk.
    Singh N; Singh R; Bowen RC; Abdel-Rahman MH; Singh AD
    Am J Ophthalmol; 2021 Apr; 224():172-177. PubMed ID: 33316260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant.
    Goldberg Y; Laitman Y; Ben David M; Bazak L; Lidzbarsky G; Salmon LB; Shkedi-Rafid S; Barshack I; Avivi C; Darawshe M; Shomron N; Bruchim R; Vinkler C; Yannoukakos D; Fostira F; Bernstein-Molho R; Friedman E
    Hum Mutat; 2021 May; 42(5):592-599. PubMed ID: 33600035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAP1 germline variants in Finnish patients with malignant mesothelioma.
    Repo P; Staskiewicz A; Sutinen E; Rönty M; Tero T Kivelä ; Myllärniemi M; Turunen JA
    Lung Cancer; 2022 Mar; 165():102-107. PubMed ID: 35114507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society.
    Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA
    J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome.
    Blatnik A; Ribnikar D; Šetrajčič Dragoš V; Novaković S; Stegel V; Grčar Kuzmanov B; Boc N; Perić B; Škerl P; Klančar G; Krajc M
    Breast Cancer; 2022 Sep; 29(5):921-927. PubMed ID: 35381901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.